MAP2K1 (MEK1), which is infrequently mutated in melanoma, colon and lung cancer, is involved in the RAS/MAPK signaling pathway, influencing various cellular processes such as growth, proliferation, and survival [35]. This evidence concerns the gene MAP2K1 and lung cancer.